Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in genetic disorders
4.1.2 Government regulations
4.2 Restraints
4.2.1 Expensive test procedures
4.3 Opportunities
4.3.1 Counselling on genetics
4.3.2 Genetic Nursing
4.4 Challenges
4.4.1 Rapid growth in technology than regulatory requirements
Chapter 5 Predictive & Presymptomatic Testing Market - By Condition
5.1 Breast and Ovarian cancer
5.2 Colorectal cancer
5.3 Alzheimer’s disease
5.4 Multiple endocrine neoplasia types 2
5.5 Haemochromatosis
Chapter 6 Predictive & Presymptomatic Testing Market - By Geography
6.1 Introduction
6.2 North America
6.2.1. The U.S.
6.2.2. Canada
6.2.3. Mexico
6.3 Europe
6.3.1. U.K.
6.3.2. Germany
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Rest of Europe
6.4 Asia Pacific
6.4.1. China
6.4.2. Japan
6.4.3. India
6.4.4. Australia & New Zealand
6.4.5. South Korea
6.4.6. Rest of APAC
6.5 South America
6.5.1. Brazil
6.5.2. Argentina
6.5.3. Others
6.6. Middle East & Africa
6.6.1. The Middle East
6.6.2. Africa
Chapter 7 Predictive & Presymptomatic Testing Market - Company Profiles
7.1. BioAxis
7.2. Genomic diagnosis
7.3. Quest Diagnostics, Inc.
7.4. Positive Bioscience
7.5. Color Genomics
7.6. Gene by Gene
7.7. 23andMe
7.8. Mapmygenome
7.9. Abbott Molecular Inc.
7.10. Direct Laboratory Services
7.11 Pathway Genomics
7.12 MyMedLab
7.13 Myriad Genetics
Chapter 8 Predictive & Presymptomatic Testing Market - Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
